About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us
More Company News
MaxCyte
Q122 results
09 May 2022
Read More
MaxCyte
CFO departure and preliminary Q122 revenue
13 Apr 2022
Read More
MaxCyte
Q421 and FY21 financial results
22 Mar 2022
Read More
MaxCyte
Cenk Sumen named Chief Scientific Officer
10 Mar 2022
Read More
MaxCyte
SPL with Intima Bioscience
01 Feb 2022
Read More
MaxCyte
Preliminary unaudited Q4 & FY21 revenue results
24 Jan 2022
Read More
MaxCyte
Q321 results
10 Nov 2021
Read More
MaxCyte
Strategic Platform Licence signed with Nkarta Inc
28 Oct 2021
Read More
MaxCyte
Q2 and H121 results and preliminary FY21 revenue guidance
13 Sep 2021
Read More
MaxCyte
Clinical and commercial licence with Sana Biotechnology
09 Aug 2021
Read More
1
2
3
4
…
9
Return to MaxCyte
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us